Delivery Order SPE2DB20D1109-SPE2DB22FN63R
- Not listed
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,740.33, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 23, 2024, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award is for the delivery of Bridion 200 mg/2 ml vials to the Defense Logistics Agency (DLA), a major agency within the U.S. Department of Defense. The award, valued at $4,030.17, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, awarded on May 2, 2024, with a completion date of May 3, 2024. The contract does not have a set-aside...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,239.51, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a firm fixed price pricing type and an ultimate completion date of August 6, 2024. This award is a delivery...
- This federal contract award is for the supply of BRIDION 500 MG/5 ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $21,456.81 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of Bridion 200 mg/2 ml vial, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $14,296.04, is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,586.07 firm fixed-price delivery order is for BRIDION 500 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
- This federal contract award is for the delivery of Bridion 200 mg/2 ml vial, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 1, 2024, with a completion date of July 2, 2024. The contract has a firm fixed price of $4,735.69 and is a delivery order. The award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is for the delivery of BRIDION 500 MG/5 ML VIAL 5ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $23,017.31, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,004.52 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2024. The contract has a completion date of November 22, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $26,190.76 and a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FN63RDelivery Order
This federal contract award is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,038.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 2/16/22 |